Sign In
Buy EQ
$3.11
+0.320 (+11.47%)
At Close: Jun 03, 2026
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
01:00pm, Wednesday, 03'rd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9 th -12 th , connecting 47 presenting small and microcap companies with distinguished investors from aroun
Equillium to Present at Jefferies Virtual Healthcare Conference
08:07pm, Thursday, 21'st May 2020
LA JOLLA, Calif., May 21, 2020 -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products.
Equillium Reports First Quarter 2020 Financial Results
08:07pm, Wednesday, 13'th May 2020
LA JOLLA, Calif., May 13, 2020 -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to.
Equillium to Present at 2020 RBC Capital Markets Virtual Global Healthcare Conference
08:07pm, Thursday, 07'th May 2020
LA JOLLA, Calif., May 07, 2020 -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products.
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q1 2020 Results - Earnings Call Transcript
02:32am, Thursday, 07'th May 2020
Start Time: 16:30 End Time: 17:13 ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2020 Earnings Conference Call May 06, 2020, 16:30 PM ET Company Participants Adam Grossm
6 Stock Charts To Watch: AUDC, DVAX, INMD, QTNT, RDHL, VKTX
12:00am, Tuesday, 28'th Apr 2020
Stocks Analysis by Harry Boxer covering: Alphabet Inc Class A, Bed Bath & Beyond Inc, Crude Oil WTI Futures, AudioCodes Ltd. Read Harry Boxer's latest article on Investing.com
Equillium Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital
08:07pm, Monday, 30'th Mar 2020
Equillium, Inc. (EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced i
Equillium Continues Graft-Versus-Host Disease Trial, Pauses 2 Others
10:12pm, Friday, 27'th Mar 2020
Equillium has halted two clinical trials of its lead drug candidate out of an “abundance of caution” related to the coronavirus outbreak but continues to
H.C. Wainwright Keeps Their Buy Rating on Equillium (EQ)
11:21am, Friday, 27'th Mar 2020
H.C. Wainwright analyst
Ram Selvaraju
reiterated a
Buy
rating on Equillium (
EQ
–
Research Report
) today and set a price target of
$14.00
. The company’s shares closed last Monday at $2.74, close
Equillium Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
08:07pm, Thursday, 26'th Mar 2020
EQUIP and EQUALISE Studies to be Paused in Response to the COVID-19 Pandemic Company Reaffirms Guidance to Report Initial Data from the EQUATE Trial in Acute GVHD in 2H 2020.
The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
11:29am, Wednesday, 25'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 24) * BELLUS Health Inc (NASDAQ: BLU) * Global Cord
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown
11:02pm, Monday, 23'rd Mar 2020
The coronavirus pandemic is narrowing the avenues open to biotechs for financing their endeavors, according to some industry veterans. “I think that fear
Equillium Strengthens Leadership Team with Key Appointments
09:14pm, Thursday, 27'th Feb 2020
Equillium, Inc. (EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced t
Equillium to Present at 9th Annual SVB Leerink Global Healthcare Conference
09:07pm, Thursday, 13'th Feb 2020
LA JOLLA, Calif., Feb. 13, 2020 -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products.
Equillium, Inc. (EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced t
